Drawing for IT-DIAB

USPTO serial 77834075

IT-DIAB

Reviewed by CopyMark Law Group

Reg. 3906325Status 710
Filing date
Status date
Registration date
Jan 18, 2011
Examiner
SALEMI, DOMINICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with IT-DIAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brooks R. Bruneau

BROOKS R. BRUNEAU PORZIO, BROMBERG & NEWMAN, P.C.29 THANET RD STE 201PRINCETON, NJ 08540-3661UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for medical use for the preventive or curative treatment of type II diabetes, of pre diabetes and their acute or chronic complications; Active principles used against type II diabetes, pre diabetes and their acute or chronic complications; Preparations for medical use with bio markers and cellular models for the in vivo, ex vivo or in vitro diagnosis of type II diabetes and of pre diabetes and their associated acute or chronic complications; Preparations for medical use with bio markers and cellular models for the medical follow-up of patients at risk or of patients suffering from type II diabetes, pre diabetes and their associated acute or chronic complications; Preparations for medical use for bio markers and cellular models for the selection and assessment of drugs and their compounds for their preventive and curative properties towards type II diabetes, pre diabetes and their associated acute or chronic complicationsSECTION 8 - CANCELLED—
009Downloadable electronic databases and files and computer programs for retrieving, compiling, integrating and sending data relating to research on type II diabetes, prediabetes and their associated acute or chronic complications in particular experimental data concerning the targets, biomarkers, cellular models and animals which are being used or developed; Downloadable electronic databases and files and computer programs for retrieving, compiling, integrating and sending data relating to methods for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Downloadable electronic databases and files and computer programs for retrieving, compiling, integrating and sending medical data relating to the condition of patients monitored for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complicationSECTION 8 - CANCELLED—
042Scientific research and information in the field of prevention, diagnosis, screening, preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Scientific research, in particular clinical research on the assessment of the effects of drugs and their compounds having preventive or curative properties of type II diabetes, prediabetes and their acute or chronic complications; Development and validation of tests for the diagnosis and medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and/or their associated acute or chronic complications; Development and validation of biological tests in vitro, ex vivo and in vivo for sorting and selecting compounds, products and substances intended for the preventive or curative treatment of type II diabetes, prediabetes and their associated acute or chronic complicationsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 25, 2017C8..CANCELLED SEC. 8 (6-YR)—
Jan 18, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 2, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 2, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 28, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 28, 2010ALIEASSIGNED TO LIE—
Sep 20, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 20, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Sep 20, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 20, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 20, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 20, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 20, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 20, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 8, 2010ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 29, 2010PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 12, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 12, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 11, 2010ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 11, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 11, 2010ALIEASSIGNED TO LIE—
Feb 22, 2010MAILPAPER RECEIVED—
Dec 28, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 21, 2009DOCKASSIGNED TO EXAMINER—
Sep 30, 2009MPMKNOTICE OF PSEUDO MARK MAILED—
Sep 29, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 28, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance